Skip to content
HowShorted

HTG MOLECULAR DIAGNOSTICS, INC short interest in 2018

In 2018, HTG MOLECULAR DIAGNOSTICS, INC's disclosed short interest ran from 14.74% of shares outstanding on 12 Jan 2018 to 11.91% on 31 Dec 2018, a change of -2.83 percentage points. The year's high was 20.18% on 15 Mar 2018 and its low 11.08% on 13 Apr 2018, averaging 14.10% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.37 days on 31 Jul 2018. Full history: HTG MOLECULAR DIAGNOSTICS, INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022

Aggregate net short position time series for HTG MOLECULAR DIAGNOSTICS, INC in 2018

2018 in figures

Start of year
14.74% (12 Jan 2018)
End of year
11.91% (31 Dec 2018)
Change
-2.83 pp
High
20.18% (15 Mar 2018)
Low
11.08% (13 Apr 2018)
Average
14.10%
Highest days to cover
16.37 (31 Jul 2018)
SEC filings marked
10

Every report in 2018

HTG MOLECULAR DIAGNOSTICS, INC short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 201814.74%1.00results (8-K)
31 Jan 201814.81%1.00results (8-K)
15 Feb 201817.68%1.00
28 Feb 201815.87%1.32
15 Mar 201820.18%2.20
29 Mar 201811.43%1.92results (8-K), 10-K filed
13 Apr 201811.08%4.84
30 Apr 201812.21%3.89
15 May 201812.81%5.5210-Q filed, results (8-K)
31 May 201812.52%10.15
15 Jun 201812.37%5.98
29 Jun 201813.84%7.94
13 Jul 201814.17%14.76
31 Jul 201814.99%16.37
15 Aug 201814.05%7.30results (8-K), 10-Q filed
31 Aug 201815.32%5.12
14 Sep 201814.58%5.09
28 Sep 201813.74%4.61
15 Oct 201814.34%5.82
31 Oct 201815.44%11.12
15 Nov 201813.66%10.7110-Q filed, results (8-K)
30 Nov 201813.07%15.14
14 Dec 201813.63%14.47
31 Dec 201811.91%8.60

See also: HTG MOLECULAR DIAGNOSTICS, INC's full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.